190 related articles for article (PubMed ID: 4589652)
41. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
Berceanu S; Gociu M
Stud Cercet Med Interna; 1969; 10(3):197-208. PubMed ID: 4186583
[No Abstract] [Full Text] [Related]
42. [Study of immunologic reactivity of the delayed (cellular) type in patients with hematoblastosis].
Libansky J
Nouv Rev Fr Hematol; 1968; 8(2):233-8. PubMed ID: 4232368
[No Abstract] [Full Text] [Related]
43. Immune responsiveness and hematologic malignancy in the elderly.
Fernandez G; Schwartz JM
Med Clin North Am; 1976; 60(6):1253-71. PubMed ID: 790049
[No Abstract] [Full Text] [Related]
44. [Immunological aspects of malignant lymphoproliferative diseases].
Rivero I; Diumenjo M
Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441
[No Abstract] [Full Text] [Related]
45. [Immunologic deficiencies in malignant diseases of the lymphoma group and in multiple myeloma].
Hartl W; Hayduk K
Arch Klin Med; 1967 Nov; 214(1):54-69. PubMed ID: 4872039
[No Abstract] [Full Text] [Related]
46. Cutaneous delayed hypersensitivity responses to tumor-associated and other antigens in acute leukemia.
Char DH; Lepourhiet BG; Herberman RB
Int J Cancer; 1973 Sep; 12(2):409-19. PubMed ID: 4524930
[No Abstract] [Full Text] [Related]
47. Passive transfer of tuberculin sensitivity to patients with Hodgkin's disease.
Müftüoğlu AU; Balkuv S
N Engl J Med; 1967 Jul; 277(3):126-9. PubMed ID: 4861560
[No Abstract] [Full Text] [Related]
48. [Immunity, leukemias and lymphomas. 5. Effects of splenectomy on the immunological condition of patients with malignant granuloma].
Danieli G; Malini PL; Montro NI M; Cremonini G; Lauria F; Tura S
G Clin Med; 1972 Jun; 53(6):277-89. PubMed ID: 4655306
[No Abstract] [Full Text] [Related]
49. [Immunotherapy and immunocorrection in the programmed treatment of hemoblastoses in children].
Makhonova LA
Gematol Transfuziol; 1984 Feb; 29(2):3-6. PubMed ID: 6546729
[No Abstract] [Full Text] [Related]
50. HL-A and lymphoid tumors.
Dick FR; Fortuny I; Theologides A; Greally J; Wood N; Yunis EJ
Cancer Res; 1972 Dec; 32(12):2608-11. PubMed ID: 4509228
[No Abstract] [Full Text] [Related]
51. [Reactivity of the lymphocytes of lymph nodes in cases of malignant lymphoma to plant agglutinin].
Stramignoni A; Navone R; Meriggi E
Boll Soc Ital Biol Sper; 1969 Feb; 45(3):194-6. PubMed ID: 4899663
[No Abstract] [Full Text] [Related]
52. Malignant disease of the lymphoid system in immunological perspective.
Hansen JA; Good RA
Hum Pathol; 1974 Sep; 5(5):567-99. PubMed ID: 4137052
[No Abstract] [Full Text] [Related]
53. HLA antigens on human peripheral lymphocytes and spleen of malignant lymphoma and other cancer patients.
Cohen E; Kim U; Blumenson L; Gregory SG; Khurana U; Cox C
Prog Clin Biol Res; 1977; 16():181-6. PubMed ID: 269456
[No Abstract] [Full Text] [Related]
54. Response in two groups of anergic patients to the transfer of leukocytes from sensitive donors.
Rodriguez Paradisi E; De Bonaparte YP; Morgenfeld MC
N Engl J Med; 1969 Apr; 280(16):859-61. PubMed ID: 4887076
[No Abstract] [Full Text] [Related]
55. [Tuberculin allergy and malignant diseases].
Chollet P; Rey M
Nouv Presse Med; 1973 Feb; 2(6):381. PubMed ID: 4569123
[No Abstract] [Full Text] [Related]
56. [TUBERCULIN ANERGY AS A CRITERION OF BIOLOGICAL DELIMITATION OF MALIGNANT RETICULOPATHIES].
POPA M; POPA G; VEIZA L
Med Interna (Bucur); 1964 Jul; 16():811-8. PubMed ID: 14182762
[No Abstract] [Full Text] [Related]
57. Immune status in untreated patients with lymphoreticular malignancy--a multifactorial study.
Hancock BW; Bruce L; Sugden P; Ward AM; Richmond J
Clin Oncol; 1977 Mar; 3(1):57-63. PubMed ID: 324686
[No Abstract] [Full Text] [Related]
58. Antibodies for mycoplasmas in normal individuals and patients with neoplasias.
Millian SJ; Spigland I
Cancer; 1966 Dec; 19(12):1820-4. PubMed ID: 5333149
[No Abstract] [Full Text] [Related]
59. HL-A antigens and hematologic malignancy.
Miller WV
Arch Intern Med; 1974 Mar; 133(3):397-9. PubMed ID: 4521322
[No Abstract] [Full Text] [Related]
60. Reactivity of lymphocytes from primary neoplasms of lymphoid tissues.
Twomey JJ; Laughter AH; Lazar S; Douglass CC
Cancer; 1976 Aug; 38(2):740-7. PubMed ID: 135638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
